14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.02 $11.93 Thursday, 25th Apr 2024 FOLD stock ended at $10.17. This is 3.51% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 4.49% from a day low at $10.02 to a day high of $10.47.
90 days $10.02 $14.03
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
Nov 30, 2023 $10.90 $11.21 $10.78 $11.02 2 210 817
Nov 29, 2023 $10.70 $10.93 $10.55 $10.76 1 566 462
Nov 28, 2023 $10.49 $10.61 $10.41 $10.58 1 774 140
Nov 27, 2023 $10.60 $10.68 $10.39 $10.55 1 458 050
Nov 24, 2023 $10.64 $10.76 $10.52 $10.59 733 203
Nov 22, 2023 $10.87 $10.96 $10.60 $10.64 1 369 198
Nov 21, 2023 $10.92 $11.05 $10.76 $10.76 1 320 149
Nov 20, 2023 $10.77 $11.17 $10.72 $11.04 1 768 700
Nov 17, 2023 $10.70 $10.94 $10.67 $10.78 2 252 721
Nov 16, 2023 $10.66 $10.76 $10.52 $10.60 1 883 639
Nov 15, 2023 $10.68 $11.21 $10.63 $10.66 2 988 638
Nov 14, 2023 $10.79 $10.93 $10.65 $10.77 2 741 857
Nov 13, 2023 $10.24 $10.49 $9.92 $10.27 1 809 618
Nov 10, 2023 $10.03 $10.48 $9.70 $10.41 4 076 261
Nov 09, 2023 $11.36 $11.39 $9.94 $9.98 4 024 994
Nov 08, 2023 $11.43 $11.81 $10.86 $11.36 2 543 486
Nov 07, 2023 $11.32 $11.79 $11.27 $11.71 3 107 762
Nov 06, 2023 $11.54 $11.60 $11.25 $11.31 2 837 178
Nov 03, 2023 $11.14 $11.66 $11.09 $11.58 3 061 043
Nov 02, 2023 $11.22 $11.32 $10.80 $10.93 1 387 255
Nov 01, 2023 $11.01 $11.09 $10.86 $10.98 2 066 976
Oct 31, 2023 $10.80 $11.01 $10.68 $10.97 1 411 470
Oct 30, 2023 $10.77 $11.01 $10.73 $10.92 1 296 140
Oct 27, 2023 $10.84 $10.92 $10.68 $10.71 2 143 650
Oct 26, 2023 $10.90 $11.06 $10.79 $10.86 1 889 858
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT